Advanced search
Publication Cover
Modern Rheumatology Volume 22, 2012 - Issue 3
Journal homepage
47
Views
3
CrossRef citations to date
0
Altmetric
Case Report

Rheumatoid arthritis complicated with immunodeficiency-associated lymphoproliferative disorders during treatment with adalimumab

Takahide IkedaDepartment of General Internal Medicine, Gifu University Graduate School of Medicine, Yanagido 1-1, Gifu 501-1194, Japan
,
Syoko ToyamaDepartment of Rheumatology, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan
,
Michihiro OgasawaraDepartment of Rheumatology, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan
,
Hirohumi AmanoDepartment of Rheumatology, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan
,
Yoshinari TakasakiDepartment of Rheumatology, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan
,
Hiroyuki MoritaDepartment of General Internal Medicine, Gifu University Graduate School of Medicine, Yanagido 1-1, Gifu 501-1194, Japan
&
Tatsuo IshizukaDepartment of General Internal Medicine, Gifu University Graduate School of Medicine, Yanagido 1-1, Gifu 501-1194, JapanCorrespondence[email protected]
 show all
Pages 458-462 | Received 01 Mar 2011, Accepted 30 Jun 2011, Published online: 02 Jan 2014

References

  • Swerdlow SH, et al. WHO classification of tumours of haema-topoietic and lymphoid tissues. 4th ed. Lyon: IARC; 2008.
  • Kauppi M, et al. Excess risk of lung cancer in patients with rheumatoid arthritis. J Rheumatol. 1996;23(8):1484–5.
  • Mellemkjaer L, et al. Rheumatoid arthritis and cancer risk. Eur J Cancer. 1996;32(10):1753–7.
  • Askling J, et al. Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antago-nists. Ann Rheum Dis. 2005;64(10):1421–6.
  • Katusic S. Occurrence of malignant neoplasms in the Rochester, Minnesota, rheumatoid arthritis cohort. Am J Med. Beard CM, Kurland LT, Weis JW, Bergstralh E.1985;78(1A):50–5.
  • Cibere J, et al. Rheumatoid arthritis and the risk of malignancy. Arthritis Rheum. 1997;40(9):1580–6.
  • Thomas E, et al. Risk of malignancy among patients with rheu-matic conditions. Int J. Cancer. 2000;88(3):497–502.
  • Ekstorm K, et al. Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first degree relatives. Arthritis Rheum. 2003;48(4):963–70.
  • Chiba N. The incidence of cancer among Japanese patients with rheumatoid arthritis in 2003 obtained by using Ninja. Mod Rheumatol. 2006;16(Suppl):202. (abstract).
  • Wolfe F, et al. Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients. Arthritis Rheum. 2004;50:1740–51.
  • Baecklund E, et al. Association of chronic inflammation not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum. 2006;54:692–701.
  • Wolfe F. Inflammatory activity, but not methotrexate or predni-sone use predicts non-Hodgkins lymphoma in rheumatoid arthritis: a 25-year study of 1,767 RA patients. Arthritis Rheum. 1998;41(Suppl 9):188.
  • Marlette X, et al. Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France. Blood. 2002;99(11):3909–15.
  • Kamel OW, et al. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol. 1996;14(6): 1943–9.
  • Harris NL, et al. World Health Organization classification of tumours. Lyon: IARC Press; 2001. p. 270.
  • Askling J, et al. Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists. Ann Rheum Dis. 2005;64: 1414–20.
  • Wolfe F, et al. The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation. Arthritis Rheum. 2007;56:1433–9.
  • Geborek P, et al. Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas. Ann Rheum Dis. 2005;64:699–703.
  • Bongartz T, et al. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies. JAMA. 2006;295:2275–85.
  • Burmester GR, et al. Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial. Ann Rheum Dis. 2007;66: 732–9.
  • Miyasaka N, The Change Study Investigators, et al. Clinical investigation in highly disease-affected rheumatoid arthritis patients in Japan with adalimumab applying standard and general evaluation: CHANGE study. Mod Rheumatol. 2008;18:252.
  • Mariette X, et al. Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry. Ann Rheum Dis. 2010;69:400–8.
  • Horiuchi T. Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents. Rheumatology. 2010;49:1215–28.
  • Baran-Marszak F, et al. Effect of tumor necrosis factor alpha and infliximab on apoptosis of B lymphocytes infected or not with Epstein-Barr virus. Cytokine. 2006;33:337–45.
  • Komatsuda A. Reversible infliximab-related lymphoproliferative disorder associated with Epstein-Barr virus in a patient with rheumatoid arthritis. Mod Rheumatol. 2008;18:315–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.